ABO ppt

21
U N I T VI Textbook of Medical Physiology, 11th Edition GUYTON & HALL Copyright © 2006 by Elsevier, Inc. Chapter 35: Blood Types; Transfusion; Tissue and Organ Transplantation Slides by Robert L. Hester, Ph.D.  

Transcript of ABO ppt

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 1/21

U N I T VI 

Textbook of Medical Physiology, 11th Edition

GUYTON & HALL 

Copyright © 2006 by Elsevier, Inc.

Chapter 35:Blood Types; Transfusion;

Tissue and Organ Transplantation

Slides by Robert L. Hester, Ph.D. 

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 3/21

Copyright © 2006 by Elsevier, Inc.

Blood Groups

Red blood cell surface antigens: glycolipids or glycoproteins

A-B-O Systemagglutinogens: surface antigens (A,B)

genes (A, B, O)

inherited (two surface chromosomes)

OO OA OB AA BB AB

also present on all cells in the body

agglutinins: gamma globulins, anti-A, anti-B, IgM, IgG

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 4/21

Copyright © 2006 by Elsevier, Inc.

Blood Groups

GENOTYPE BLOOD TYPE AGGLUTINOGENS AGGLUTININS

OO

OA or AA

OB or BB

AB

O

A

B

AB

------

A

B

AB

ANTI-A

ANTI-B

ANTI-A and

ANTI-B

------

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 5/21

Copyright © 2006 by Elsevier, Inc.

Titer of Agglutinins

• After birth –  almostzero

• 2-8 months after birth –  begin production

• 8-10 years old –  maximum titer

• Gradually declinesremaining years of life

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 6/21

Copyright © 2006 by Elsevier, Inc.

Blood Typing

BLOOD TYPE ANTI-A ANTI-B

O

A

B

AB

------

++

------

------

+

+

------

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 7/21Copyright © 2006 by Elsevier, Inc.

Blood Groups

Rhesus System

agglutinogens: 6 rhesus factors (C, D, E, c, d, e)

inherited as triplets

CDE, CDe, Cde, CdE, cDE, cDe, cde

antigen D =Rhesus positive (widely

 prevalent & more antigenic)

agglutinins: do not occur spontaneously, only after

exposure to Rh antigens

Rh+ blood into Rh negative person:

sensitization to further Rh+ transfusion

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 8/21Copyright © 2006 by Elsevier, Inc.

•Disease of the fetus and newborn child

•Fetal blood enters maternal circulation

•Agglutination & phagocytosis of fetus’ RBCs 

• ABO incompatibility

•O mother and A or B fetus

•IgG anti-A and anti-B cross placenta

•very mild effects

Hemolytic Disease of the Newborn or

Erythroblastosis fetalis

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 9/21Copyright © 2006 by Elsevier, Inc.

•Rh incompatibility

•Rh positive fetus and a Rh negative mother

•Anti-D agglutinins form in mother from exposure to

fetus’ Rh Ag

 diffusion thru the placenta into the fetusand cause agglutination

•Maternal blood with anti-D usually circulate in infant’s

 blood for another 1-2 months after birth destroys more

RBC

•More critical with 2nd and succeeding Rh positive child

Hemolytic Disease of the Newborn or

Erythroblastosis fetalis

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 10/21Copyright © 2006 by Elsevier, Inc.

Hemolytic Disease of the Newborn or

Erythroblastosis fetalis

• Signs and Symptoms

1. Jaundice

2. Pallor or anemia at birth3. Hepatosplenomegaly  – forming nucleated blastic

RBCs

4. kernicterus

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 11/21Copyright © 2006 by Elsevier, Inc.

•   Treatment

1. Exchange Transfusion

• Replace neonate’s blood with Rh (-) blood

• > 6 weeks - transfused Rh (-) blood is replaced byinfant’s own Rh (+) blood and mother’s anti-D is

destroyed

2. Injection of IgG anti-D or Rh Ig or Rhogam

• to expectant mother starting at 28-30 weeks AOG

Hemolytic Disease of the Newborn or

Erythroblastosis fetalis

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 12/21Copyright © 2006 by Elsevier, Inc.

• Prevention

• Administer Rhogam to Rh (-) mother who delivered

Rh (+) babies to prevent sensitization of mother to

the D Ag, thus, reducing the risk of developing largeamounts of anti-D during 2nd pregnancy

Mechanism of Rhogam

• inhibits Ag-induced B lymphocytic Ab production in

expectant mothers• Attaches to D-Ag sites on Rh (+) fetal RBC that

may cross the placenta

Hemolytic Disease of the Newborn or

Erythroblastosis fetalis

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 13/21Copyright © 2006 by Elsevier, Inc.

Transfusion Reaction

Hemolysins – IgG agglutinins contain 2 binding sites

 – IgM agglutinins contain 10 binding sites

Agglutination = “clumping” of cells by activation ofcomplement system (Ag-Ab reaction) release

 proteolytic enzymes destroys membrane of

agglutinated cells (either by physical distortion ofcells or phagocytosis by WBC) release of Hb hemolysis

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 14/21Copyright © 2006 by Elsevier, Inc.

Transfusion Reaction

• Transfusion reaction due to agglutination of

donor blood and rarely recipient’s blooddue to –  plasma portion of donor blood

immediately becomes diluted by plasma of

recipient decreasing titer of transfused

agglutinins

• DONOR’S BLOOD undergoes hemolysis 

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 15/21Copyright © 2006 by Elsevier, Inc.

Transfusion Reaction

• Signs and Symptoms

1. Fever and chills2. Shortness of breath

3. Jaundice

4. Shock

5. Renal shutdown

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 16/21Copyright © 2006 by Elsevier, Inc.

Transfusion Reaction

• Renal Shotdown or Renal Failure1. Renal Vasoconstrictor   – toxic substance

released by hemolyzed blood

2. Circulatory Shock  –

 due to loss of circulatingRBC, the produced toxic substances and fromimmune reaction (Ag-Ab reaction)  – hypotension,decrease renal blood flow, decrease urine output

3. Renal Tubular Blockage  – total amount of free

Hb released into the circulating blood > Hbbound to haptoglobin excess leaks thru theglomerular membrane into kidney tubules, whichprecipitates and blocks renal tubules

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 17/21Copyright © 2006 by Elsevier, Inc.

Transplantation

• Autograft –  same animal

• Isograft –  identical twin• Allograft –  same species

• Xenograft –  different species

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 18/21Copyright © 2006 by Elsevier, Inc.

Transplantation

• HLA Ab

 – Most important Ab causing graft rejection

 –150 Ab 6 on tissue cell membrane (WBC andtissue cells)

• HLA Typing –  test for rate of trans-

membrane uptake by WBC of a special dye

• OBTAIN THE BEST POSSIBLE MATCH

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 19/21Copyright © 2006 by Elsevier, Inc.

Transplantation

• Rejection ---- mainly due to activation ofT-cells

• Suppressive therapy---- inhibit immune

response not protected from infectiousdiseases and sometimes even cancer

1. glucocorticoids – limits growth of all lymphoidtissuesdecrease formation of Ab and T cells

2. azathioprine - inhibits formation of Ab and T cells3. cyclosporine --- specific inhibitor of helper T-cell

formation; most valuable because it does notsuppress other portions of the immune system

8/20/2019 ABO ppt

http://slidepdf.com/reader/full/abo-ppt 21/21

U N I T VI 

Textbook of Medical Physiology, 11th Edition

GUYTON & HALL 

Thank you